Previous close | 66.52 |
Open | 66.96 |
Bid | 66.89 x 100 |
Ask | 67.28 x 100 |
Day's range | 66.78 - 67.87 |
52-week range | 37.87 - 70.81 |
Volume | |
Avg. volume | 145,693 |
Market cap | 1.408B |
Beta (5Y monthly) | 0.80 |
PE ratio (TTM) | 78.95 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Moderna (MRNA) beats expectations for both earnings and sales. Management reiterates guidance to record around $4 billion from product sales in 2024.
GSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The company raises guidance for earnings and sales for the full year.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.